CM
CDNA icon

Castleark Management’s CareDx CDNA Stock Holding History

Castleark Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-198,180
Closed -$4.24M – 295
2024
Q4 		$4.24M Buy
198,180
+58,300
+42% +$1.42M 0.15% 148
2024
Q3 		$4.37M Buy
+139,880
New +$3.48M 0.18% 131
2021
Q4 		– Sell
-71,720
Closed -$4.54M – 333
2021
Q3 		$4.54M Buy
+71,720
New +$5.46M 0.17% 134
2021
Q1 		– Sell
-199,897
Closed -$14.5M – 340
2020
Q4 		$14.5M Sell
199,897
-118,918
-37% -$6.89M 0.54% 41
2020
Q3 		$12.1M Buy
318,815
+36,118
+13% +$1.22M 0.47% 52
2020
Q2 		$10M Buy
+282,697
New +$8.05M 0.44% 52
2019
Q2 		– Sell
-196,005
Closed -$6.18M – 357
2019
Q1 		$6.18M Sell
196,005
-75,965
-28% -$2.21M 0.23% 141
2018
Q4 		$6.84M Buy
271,970
+63,735
+31% +$1.64M 0.29% 103
2018
Q3 		$6.01M Buy
+208,235
New +$3.9M 0.17% 176

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Castleark Management's CDNA Position: Q1 2025 in Review

Castleark Management sold out of CareDx (CDNA) in Q1 2025, closing a stake of 198,180 shares — an estimated $4.24M sold.

Castleark Management first reported a position in CDNA in Q3 2018 and held it in 9 quarters. The position peaked at $14.5M in Q4 2020. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Castleark Management reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • Castleark Management sold 198,180 CareDx shares in Q1 2025, an estimated $4.24M.
  • Castleark Management first reported a position in CareDx in Q3 2018 and held it in 9 quarters.
  • Castleark Management's CareDx position peaked at $14.5M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Castleark Management's 13F filing for Q1 2025, filed 15 May 2025.